Spinal cord neurosarcoidosis

American Journal of the Medical Sciences

Volumn 347, Issue 3, 2014, Pages 195-198

  Sohn, Mimi ^a   Culver, Daniel A ^b   Judson, Marc A ^a,d   Scott, Thomas F ^c   Tavee, Jinny ^b   Nozaki, Kenkichi ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cerebral spinal fluid; Immunosuppresive treatment; Magnetic resonance imaging; Neurosarcoidosis; Spinal cord

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID;

ADULT; ARM WEAKNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FECES INCONTINENCE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; RANK SUM TEST; RANKIN SCALE; RETROSPECTIVE STUDY; SARCOIDOSIS; SPINAL CORD DISEASE; SPINAL CORD NEUROSARCOIDOSIS; UNIVERSITY HOSPITAL; URINE INCONTINENCE; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LYMPH NODES; MALE; MIDDLE AGED; SARCOIDOSIS; SPINAL CORD; YOUNG ADULT;

EID: 84896726501     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182808781     Document Type: Article

References (40)

1. Judson MA. Sarcoidosis: Clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 2008;335:26-33.
2. Hoitsma E, Faber CG, Drent M, et al. Neurosarcoidosis: A clinical dilemma. Lancet Neurol 2004;3:397-407.
3. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990;69: 261-276.
4. Cohen-Aubart F, Galanaud D, Grabli D, et al. Spinal cord sarcoidosis: Clinical and laboratory profile and outcome of 31 patients in a case control study. Medicine (Baltimore) 2010;89:133-140.
5. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: Spectrum of manifestations and radiographic response to steroid therapy. Am J Neuroradiol 1994;15:973-982.
6. Duhon BS, Shah L, Schmidt MH. Isolated intramedullary neurosarcoidosis of the thoracic spine: Case report and review of the literature. Eur Spine J 2012;21(suppl 4):S390-S395.
7. Bradley DA, Lower EE, Baughman RP. Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006;23: 58-65.
8. Day AL, Sypert GW. Spinal cord sarcoidosis. Ann Neurol 1977;1: 79-85.
9. Joseph FG, Scolding NJ. Sarcoidosis of the nervous system. Pract Neurol 2007;7:234-244.
10. Junger SS, Stern BJ, Levine SR, et al. Intramedullary spinal sarcoidosis: Clinical and magnetic resonance imaging characteristics. Neurology 1993;43:333-337.
11. Scott TF, Yandora K, Valeri A, et al. Aggressive therapy for neurosarcoidosis: Long-Term follow-up of 48 treated patients. Arch Neurol 2007;64:691-696.
12. Kumar N, Frohman EM. Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating syndrome. Arch Neurol 2004;61: 586-589.
13. van Swieten JC, Koudstaal PJ, VisserMC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
14. Christoforidis GA, Spickler EM, Recio MV, et al. MR of CNS sarcoidosis: Correlation of imaging features to clinical symptoms and response to treatment. Am J Neuroradiol 1999;20:655-669.
15. Costabel U. Sarcoidosis: Clinical update. Eur Respir J 2001;32:56s-68s.
16. Hayat GR, Walton TP, Smith KR, et al. Solitary intramedullary neurosarcoidosis: Role of MRI in early detection. J Neuroimaging 2001;11:66-70.
17. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 2004;182:289-295.
18. Spencer TS, Campellone JV, Maldonado I, et al. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005;34:649-661.
19. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: Spectrum of manifestations and radiographic response to steroid therapy. Am J Neuroradiol 1984;15:973-982.
20. Pascuzzi RM, Shapiro SA, Rau AN, et al. Sarcoid myelopathy. J Neuroimaging 1996;6:61-62.
21. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995;195:725-732.
22. Bot JC, Barkhof F. Spinal-cord MRI in multiple sclerosis: Conventional and nonconventional MR techniques. Neuroimaging Clin N Am 2009;19:81-99.
23. Bot JC, Barkhof F, Polman CH, et al. Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination. Neurology 2004;62:226-233.
24. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995:725-732.
25. Trebst C, Raab P, Voss EV, et al. Longitudinal extensive transverse myelitis-it's not all neuromyelitis optica. Nat Rev Neurol. 2011;7: 688-698.
26. Sakushima K, Yabe I, Nakano F, et al. Clinical features of spinal cord sarcoidosis: Analysis of 17 neurosarcoidosis patients. J Neurol 2011; 258:2163-2167.
27. Varron L, Broussolle C, Candessanche JP, et al. Spinal cord sarcoidosis: Report of seven cases. Eur J Neurol 2009;16:289-296.
28. Sharma OP. Neurosarcoidosis: A personal perspective based on the study of 37 patients. Chest 1997;112:220-228.
29. Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med 2008;29:533-548.
30. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: A study of 54 cases. QJM 2009;102:449-460.
31. Baughman RP. Therapeutic options for sarcoidosis: New and old. Curr Opin Pulm Med 2002;8:464-469.
32. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997;157:1864-1868.
33. Sahoo DH, Bandyopadhyay D, Xu M, et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 2011;38:1145-1150.
34. Chaussenot A, Bourg V, Chanalet S, et al. Neurosarcoidosis treated with mycophenolate mofetil: Two cases. Rev Neurol (Paris) 2007;163: 471-475.
35. Marnane M, Lynch T, Scott J, et al. Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab. J Neurol 2009;256:139-140.
36. Sollberger M, Fluri F, Baumann T, et al. Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol 2004; 251:760-761.
37. Doty JD,Mazur JE, JudsonMA. Treatment of sarcoidosis with infliximab. Chest 2005;127:1064-1071.
38. Pettersen JA, Zochodne DW, Bell RB, et al. Refractory neurosarcoidosis responding to infliximab. Neurology 2002;59:1660-1661.
39. Santos E, Shaunak S, Renowden S, et al. Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry 2010;81:241-246.
40. Sodhi M, Pearson K, White ES, et al. Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis. Respir Med 2009;103:268-267.